<DOC>
	<DOCNO>NCT01963728</DOCNO>
	<brief_summary>To determine use insulin isophane result improve control blood sugar compare use insulin glargine new onset diabetes kidney , lung , heart transplantation ( NODAT ) .</brief_summary>
	<brief_title>Comparison Insulin Therapy Treating Post-Transplant Diabetes</brief_title>
	<detailed_description>A large percentage organ transplant recipient develop de novo diabetes mellitus transplantation , also call `` New Onset Diabetes After Transplant '' NODAT . The cause diabetes appear commonly use anti-rejection medication , particularly calcineurin inhibitor glucocorticoid . Management glucose level NODAT often require insulin therapy . Standard practice start long-acting insulin . However , patient NODAT often exhibit fast morning glucose level relatively low compare pre-lunch pre-dinner glucose level . This seem make NODAT patient susceptible fasting , morning , hypoglycemia long-acting insulin analogue non-transplant patient type II diabetes . This phenomenon morning hypoglycemia NODAT often limit up-titration basal insulin result suboptimal treatment hyperglycemia later day . Because pattern , transplant patient may respond good morning insulin isophane ( intermediate acting ) long-acting insulin glargine preparation . Our trial design compare morning NPH insulin ( isophane insulin ) conventional therapy basal glargine insulin continuous blood glucose level hemoglobin A1c ( glycosylated hemoglobin ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<criteria>1 . Must follow Inova Fairfax Hospital transplantation program posttransplant care 2 . Diabetes mellitus inadequately responsive lifestyle modification noninsulin hypoglycemic medication 3 . Need subcutaneous insulin therapy ( discontinuation IV insulin therapy , require ) 4 . Ability read consent form give consent English . 1 . Use insulin noninsulin hypoglycemic medication transplantation 2 . Cystic fibrosis patient 3 . Age &lt; 18 year age 4 . Pregnancy 5 . NonEnglish speaking subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>post-transplant</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>renal transplant</keyword>
	<keyword>kidney transplant</keyword>
	<keyword>lung transplant</keyword>
	<keyword>heart transplant</keyword>
	<keyword>insulin</keyword>
</DOC>